6 Results for "

BTK-IN-5

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "BTK-IN-5" in MCE Product Catalog:

Cat. No.: HY-115876
CAS No.: 2145152-06-1
BTK-IN-5 is a covalent BTK inhibitor for researching medical conditions such as cardiovascular diseases, respiratory diseases, inflammation, and diabetes.
loading...
    loading...
Cat. No.: HY-155072
CAS No.: 3049086-75-8
Target:  

PROTACs Btk

Research Areas:  

Cancer

PROTAC BTK degraders-5(compound 3e) is a selective BTK PROTAC degrader with a DC50 value of 7.0 nM in JeKo-1 cells. PROTAC BTK degraders-5 has no off-target effect on degrading CRBN neosubstates. PROTAC BTK degraders-5 has anti-proliferation effect on various lymphoma tumor cells and can be used in chronic lymphoid malignancies research .
loading...
    loading...
Cat. No.: HY-143720
CAS No.: 2673196-75-1
Target:  

JAK Btk

Research Areas:  

Inflammation/Immunology

JAK3/BTK-IN-5 is a potent inhibitor of JAK3/BTK. BTK and JAK3 are two important targets for autoimmune diseases. Simultaneous inhibition of the BTK/JAK3 signalling pathway exhibits synergistic effects. JAK3/BTK-IN-5 has the potential for the research of JAK3 kinase and/or BTK-related diseases (extracted from patent WO2021147953A1, example 35)
loading...
    loading...
Cat. No.: HY-168297
Research Areas:  

Cancer

Piperidine-C2-Pip-C-COOH is a linker for PROTAC BTK Degrader-5 (HY-155072), significantly improving metabolic stability, and can be used in cancer research .
loading...
    loading...
Cat. No.: HY-168298
Research Areas:  

Cancer

Lenalidomide-6-F-piperidine-C2-Pip-C-COOH is a linker and E3 ligase ligand for PROTAC BTK Degrader-5 (HY-155072) and can be used in malignant lymphoma research .
loading...
    loading...
Cat. No.: HY-150898
CAS No.: 2192282-58-7
Research Areas:  

Others

BTK ligand 3 is a BTK ligand that can be used for the synthesis of PROTACs, such as PROTAC BTK Degrader-5 (HY-155072) .
loading...
    loading...